Skip to main content
ABCL
NASDAQ Life Sciences

AbCellera Narrows Q3 Loss to $40.8M as ABCL635 Phase 2 Data Drives $200M Raise

Tom Rudovsky · Reported by BusinessWire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$12.9
Mkt Cap
$4.051B
52W Low
$2.745
52W High
$15.015
52W Position info
370% above low
Off High info
14% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

ABCL has more than doubled off its 52-week low of $2.745.

Summary

AbCellera reported Q3 2026 revenue of $10.6 million versus $9.0 million a year ago, while net loss narrowed to $40.8 million from $57.1 million as R&D and SG&A spending both fell. The quarter's centerpiece was positive top-line Phase 2 data for ABCL635 in menopausal vasomotor symptoms, which the company says supports late-stage development starting in 2027 and expansion into hormone-suppression-induced VMS in breast and prostate cancer patients. On the strength of that data AbCellera completed the $200 million offering priced in August at $9.75, lifting total available liquidity to over $890 million against a $4.05 billion market cap. The subsequent Phase 1 readout for ABCL575 met all endpoints but the company does not plan to advance it past Phase 1, and partner-led programs slipped to 34 from 44 at year-end 2025. Watch the 2027 late-stage ABCL635 trial start and the IND-enabling work on ABCL386, ABCL688, ABCL992, ABCL385 and ABCL646.

At the time of this announcement, ABCL was trading at $12.90 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.1B. The 52-week trading range was $2.75 to $15.02. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

ABCL - Latest Insights

ABCL
Nov 09, 2026, 4:22 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $12.54
Real-time Price: $12.98 info
Change: +$0.4367 (+3%) info
Market Cap: $4.051B info
ABCL
Aug 13, 2026, 4:33 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $10.97
Real-time Price: $12.98 info
Change: +$2.01 (+18%) info
Market Cap: $4.051B info
ABCL
Aug 13, 2026, 12:05 AM EDT
Source: BusinessWire
Importance Score:
9
Price at Filing: $10.32
Real-time Price: $12.98 info
Change: +$2.66 (+26%) info
Market Cap: $4.051B info
ABCL
Aug 11, 2026, 4:59 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $9.32
Real-time Price: $12.98 info
Change: +$3.66 (+39%) info
Market Cap: $4.051B info
ABCL
Aug 11, 2026, 4:01 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $9.76
Real-time Price: $12.98 info
Change: +$3.22 (+33%) info
Market Cap: $4.051B info